115 related articles for article (PubMed ID: 8769215)
1. Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral.
Baruch Y; Weitzman E; Markiewicz W; Eisenman A; Eid A; Enat R
Transplant Proc; 1996 Aug; 28(4):2250-1. PubMed ID: 8769215
[No Abstract] [Full Text] [Related]
2. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
[No Abstract] [Full Text] [Related]
3. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
[TBL] [Abstract][Full Text] [Related]
4. Reversal of tacrolimus-related hypertrophic cardiomyopathy after conversion to rapamycin in a pediatric liver transplant recipient.
Turska-Kmieć A; Jankowska I; Pawłowska J; Kaliciński P; Kawalec W; Tomyn M; Markiewicz M; Teisseyre J; Czubkowski P; Rekawek J; Socha J
Pediatr Transplant; 2007 May; 11(3):319-23. PubMed ID: 17430490
[TBL] [Abstract][Full Text] [Related]
5. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
Reggiani P; Rossi G; Latham L; Caccamo L; Gatti S; Maggi U; Melada E; Paone G; Doglia M; Vannelli A; Fassati LR
Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
[No Abstract] [Full Text] [Related]
6. Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients.
Lagget M; Marzano A; Actis GC; Leone N; Ciancio A; Salizzoni M; Rizzetto M
Transplant Proc; 1998 Aug; 30(5):1863-4. PubMed ID: 9723312
[No Abstract] [Full Text] [Related]
7. Tacrolimus: a cause of hypertrophic cardiomyopathy in pediatric heart transplant recipients?
Scott JS; Boyle GJ; Daubeney PE; Miller SA; Law Y; Pigula F; Griffith BP; Webber SA
Transplant Proc; 1999; 31(1-2):82-3. PubMed ID: 10083017
[No Abstract] [Full Text] [Related]
8. Improvement in correlation between oral dose of cyclosporine and cyclosporinemia after substitution of conventional cyclosporine by Neoral cyclosporine in 296 liver transplant patients.
Bilbao I; Parrilla P; Rimola A; Figueras J; Fabrega E; Gomez M; De Vicente E; Margarit C
Transplant Proc; 1998 Aug; 30(5):1833-7. PubMed ID: 9723300
[No Abstract] [Full Text] [Related]
9. Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients.
Ogino S; Hashikura Y; Katsuyama Y; Ikegami T; Nakazawa Y; Urata K; Terada M; Miyagawa S; Kawasaki S
Transplant Proc; 2004 Mar; 36(2 Suppl):299S-301S. PubMed ID: 15041357
[TBL] [Abstract][Full Text] [Related]
10. Potential role of Neoral in pediatric liver transplantation.
Whitington PF; Alonso EM; Millis JM
Transplant Proc; 1996 Aug; 28(4):2267-9. PubMed ID: 8769221
[No Abstract] [Full Text] [Related]
11. Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients.
Baruch Y; Assy N; Kramsky R; Enat R
Transplant Proc; 1998 Aug; 30(5):1852-3. PubMed ID: 9723306
[No Abstract] [Full Text] [Related]
12. Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients.
Dehghani SM; Haghighat M; Imanieh MH; Zahmatkeshan M; Borzooei M; Amoozegar H; Zamirian M; Gholami S; Bahador A; Nikeghbalian S; Salahi H; Malek-Hosseini SA
Arch Iran Med; 2010 Mar; 13(2):116-9. PubMed ID: 20187665
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient.
Falkenstein K; Dunn S
Transplant Proc; 1998 Aug; 30(5):1964-6. PubMed ID: 9723354
[No Abstract] [Full Text] [Related]
14. Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation.
Chang RK; McDiarmid SV; Alejos JC; Drant SE; Klitzner TS
Pediatr Transplant; 2001 Jun; 5(3):187-91. PubMed ID: 11422821
[TBL] [Abstract][Full Text] [Related]
15. Conversion from tacrolimus to Neoral in liver and kidney transplant recipients.
Ott R; Bussenius-Kammerer M; Scholz D; Neuhaus R; Tolba RH; Fricke L; Müller V
Transplant Proc; 2001; 33(7-8):3166-8. PubMed ID: 11750359
[No Abstract] [Full Text] [Related]
16. Frequency of switch from cyclosporine to FK 506 before and after Neoral use in pediatric liver transplantation.
Gridelli B; Colledan M; Lucianetti A; Ulla L; Riva S; Segalin A; Fassati LR; Torre G
Transplant Proc; 1998 Aug; 30(5):1861-2. PubMed ID: 9723311
[No Abstract] [Full Text] [Related]
17. Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.
Dibo-Cohen JM; Conort O; Conti F; Bernard D; Hazebroucq G; Calmus Y
Transplant Proc; 1998 Aug; 30(5):1857. PubMed ID: 9723309
[No Abstract] [Full Text] [Related]
18. Results of conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients after two years.
Dunn SP; Falkenstein K; Pierson A; Cooney GF
Transplant Proc; 1998 Aug; 30(5):1962-3. PubMed ID: 9723353
[No Abstract] [Full Text] [Related]
19. Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient.
Liu T; Gao Y; Gao YL; Cheng YT; Wang S; Li ZZ; Zhang HB; Meng X; Ma CS; Dong JZ
Chin Med J (Engl); 2012 Apr; 125(7):1352-4. PubMed ID: 22613615
[TBL] [Abstract][Full Text] [Related]
20. Interim analysis of study OLN-356: Neoral versus Sandimmune in US primary liver transplant recipients. OLN-356 Principal Investigators.
Pinson CW; Beauregard-Zollinger L
Transplant Proc; 1996 Aug; 28(4):2234-6. PubMed ID: 8769209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
